View in EDS HTML Full Text PDF Full Text

A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.

Saved in:
Bibliographic Details
Title: A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.
Authors: Zhou, Mingzhen1,2, Jin, Yuncheng1, Zhu, Sihui3, Xu, Chen3, Li, Lin1,2,4, Liu, Baorui1,2 baoruiliu@nju.edu.cn, Shen, Jie1,2,5 shenjie2008nju@163.com
Source: Clinical & Translational Immunology. 2024, Vol. 13 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 175056283
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Zhou%2C+Mingzhen%22">Zhou, Mingzhen</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Jin%2C+Yuncheng%22">Jin, Yuncheng</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Zhu%2C+Sihui%22">Zhu, Sihui</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Xu%2C+Chen%22">Xu, Chen</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Li%2C+Lin%22">Li, Lin</searchLink><relatesTo>1,2,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Liu%2C+Baorui%22">Liu, Baorui</searchLink><relatesTo>1,2</relatesTo><i> baoruiliu@nju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Shen%2C+Jie%22">Shen, Jie</searchLink><relatesTo>1,2,5</relatesTo><i> shenjie2008nju@163.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Translational+Immunology%22">Clinical & Translational Immunology</searchLink>. 2024, Vol. 13 Issue 1, p1-11. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=175056283
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cti2.1483
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Titles:
      – TitleFull: A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhou, Mingzhen
      – PersonEntity:
          Name:
            NameFull: Jin, Yuncheng
      – PersonEntity:
          Name:
            NameFull: Zhu, Sihui
      – PersonEntity:
          Name:
            NameFull: Xu, Chen
      – PersonEntity:
          Name:
            NameFull: Li, Lin
      – PersonEntity:
          Name:
            NameFull: Liu, Baorui
      – PersonEntity:
          Name:
            NameFull: Shen, Jie
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20500068
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical & Translational Immunology
              Type: main
ResultId 1